Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of (Dollar) 27 billion by 2029. Obesity Drug Set to Exceed Ozempic With (Dollar) 27B Sales by 2029
Medindia »
·
·
91 views
Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of (Dollar) 27 billion by 2029.
Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of (Dollar) 27 billion by 2029. 
SlashGear 
Dynamic Business 
Editorialge 
Mommy Levy 
The Politics Guys 
Channel NewsAsia - World 
